S-3 Registration statement for specified transactions by certain issuers
- Filed
- Accession number
- 0001213900-26-092612
Documents
- REGISTRATION STATEMENT S-3
- AMENDMENT NO. 1 TO THE SALES AGREEMENT BETWEEN ORUKA THERAPEUTICS, INC. AND TD SECURITIES (USA) LLC, DATED AUGUST 21, 2026 EX-1.3
- OPINION OF DAVIS POLK & WARDWELL LLP RELATING TO THE BASE PROSPECTUS EX-5.1
- OPINION OF DAVIS POLK & WARDWELL LLP RELATING TO THE SALES AGREEMENT PROSPECTUS EX-5.2
- CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EX-23.1
- FILING FEE TABLE EX-FILING FEES